Magna pars studiorum, prodita quaerimus. Phasellus laoreet lorem vel dolor tempus vehicula. Nec dubitamus multa iter quae et nos invenerat. Quisque placerat facilisis egestas cillum dolore.
Quisque ut dolor gravida, placerat libero vel, euismod. Quae vero auctorem tractata ab fiducia dicuntur.
AACR Applauds FDA’s New Steps to Address Epidemic of Youth E-cigarette Use
Learn More
FDA Approves New PARP Inhibitor for BRCA-mutant Ovarian Cancer
Learn More
Supporting the Vital Role of Women in Science
Learn More
A Family Affair: Breast Cancer Prevention for Mothers, Daughters, and Women of All Ages
Learn More
Film Succeeds in Relaying the Complexity and Hope of Cancer Treatment
Learn More
Differences and Disparities in Cancer
Learn More
New Combination Chemotherapy for Colorectal Cancer
Learn More
AACR Philadelphia Marathon Makes a Triumphant Return
Learn More
Annual Meeting 2022: Opening Plenary Showcases Cutting-edge Scientific Program
Learn MoreFDA Approves Fourth Immune Checkpoint Inhibitor for Bladder Cancer
Learn MoreWe have made spectacular progress against cancer thanks to breakthroughs in cancer science. However, with more than 600,000 people in the United States projected to die from cancer this year, our work is not done. Get involved to ensure that the momentum continues: